Literature DB >> 25258312

DEPTOR is a stemness factor that regulates pluripotency of embryonic stem cells.

Pooja Agrawal1, Joseph Reynolds1, Shereen Chew1, Deepak A Lamba2, Robert E Hughes3.   

Abstract

The mammalian target of rapamycin (mTOR) pathway regulates stem cell regeneration and differentiation in response to growth factors, nutrients, cellular energetics, and various extrinsic stressors. Inhibition of mTOR activity has been shown to enhance the regenerative potential of pluripotent stem cells. DEPTOR is the only known endogenous inhibitor of all known cellular mTOR functions. We show that DEPTOR plays a key role in maintaining stem cell pluripotency by limiting mTOR activity in undifferentiated embryonic stem cells (ESCs). DEPTOR levels dramatically decrease with differentiation of mouse ESCs, and knockdown of DEPTOR is sufficient to promote ESC differentiation. A strong decrease in DEPTOR expression is also observed during human ESCs differentiation. Furthermore, reduction in DEPTOR level during differentiation is accompanied by a corresponding increase in mTOR complex 1 activity in mouse ESCs. Our data provide evidence that DEPTOR is a novel stemness factor that promotes pluripotency and self-renewal in ESCs by inhibiting mTOR signaling.
© 2014 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  Cell Differentiation; Cell Signaling; Embryonic Stem Cell; Mammalian Target of Rapamycin (mTOR); Neurogenesis

Mesh:

Substances:

Year:  2014        PMID: 25258312      PMCID: PMC4231659          DOI: 10.1074/jbc.M114.565838

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  44 in total

1.  DEPTOR is an mTOR inhibitor frequently overexpressed in multiple myeloma cells and required for their survival.

Authors:  Timothy R Peterson; Mathieu Laplante; Carson C Thoreen; Yasemin Sancak; Seong A Kang; W Michael Kuehl; Nathanael S Gray; David M Sabatini
Journal:  Cell       Date:  2009-05-14       Impact factor: 41.582

2.  USP9X enhances the polarity and self-renewal of embryonic stem cell-derived neural progenitors.

Authors:  Lachlan A Jolly; Verdon Taylor; Stephen A Wood
Journal:  Mol Biol Cell       Date:  2009-01-28       Impact factor: 4.138

Review 3.  Upstream of the mammalian target of rapamycin: do all roads pass through mTOR?

Authors:  M N Corradetti; K-L Guan
Journal:  Oncogene       Date:  2006-10-16       Impact factor: 9.867

4.  Spatial organization of embryonic stem cell responsiveness to autocrine gp130 ligands reveals an autoregulatory stem cell niche.

Authors:  Ryan E Davey; Peter W Zandstra
Journal:  Stem Cells       Date:  2006-07-06       Impact factor: 6.277

5.  Suppression of Erk signalling promotes ground state pluripotency in the mouse embryo.

Authors:  Jennifer Nichols; Jose Silva; Mila Roode; Austin Smith
Journal:  Development       Date:  2009-08-26       Impact factor: 6.868

6.  mTOR mediates Wnt-induced epidermal stem cell exhaustion and aging.

Authors:  Rogerio M Castilho; Cristiane H Squarize; Lewis A Chodosh; Bart O Williams; J Silvio Gutkind
Journal:  Cell Stem Cell       Date:  2009-09-04       Impact factor: 24.633

7.  Transplantation of human embryonic stem cell-derived photoreceptors restores some visual function in Crx-deficient mice.

Authors:  Deepak A Lamba; Juliane Gust; Thomas A Reh
Journal:  Cell Stem Cell       Date:  2009-01-09       Impact factor: 24.633

8.  mTOR supports long-term self-renewal and suppresses mesoderm and endoderm activities of human embryonic stem cells.

Authors:  Jiaxi Zhou; Pei Su; Lu Wang; Joanna Chen; Maike Zimmermann; Olga Genbacev; Olubunmi Afonja; Mary C Horne; Tetsuya Tanaka; Enkui Duan; Susan J Fisher; Jiayu Liao; Jie Chen; Fei Wang
Journal:  Proc Natl Acad Sci U S A       Date:  2009-04-28       Impact factor: 11.205

9.  Characterization of Rictor phosphorylation sites reveals direct regulation of mTOR complex 2 by S6K1.

Authors:  Christian C Dibble; John M Asara; Brendan D Manning
Journal:  Mol Cell Biol       Date:  2009-08-31       Impact factor: 4.272

10.  Control of hematopoietic stem cell quiescence by the E3 ubiquitin ligase Fbw7.

Authors:  Benjamin J Thompson; Vladimir Jankovic; Jie Gao; Silvia Buonamici; Alan Vest; Jennifer May Lee; Jiri Zavadil; Stephen D Nimer; Iannis Aifantis
Journal:  J Exp Med       Date:  2008-05-12       Impact factor: 14.307

View more
  15 in total

Review 1.  mTOR signaling in stem and progenitor cells.

Authors:  Delong Meng; Anderson R Frank; Jenna L Jewell
Journal:  Development       Date:  2018-01-08       Impact factor: 6.868

Review 2.  Pluripotent stem cell energy metabolism: an update.

Authors:  Tara Teslaa; Michael A Teitell
Journal:  EMBO J       Date:  2014-12-04       Impact factor: 11.598

Review 3.  Connecting Mitochondria, Metabolism, and Stem Cell Fate.

Authors:  Anaïs Wanet; Thierry Arnould; Mustapha Najimi; Patricia Renard
Journal:  Stem Cells Dev       Date:  2015-07-02       Impact factor: 3.272

Review 4.  Deptor: not only a mTOR inhibitor.

Authors:  Valeria Catena; Maurizio Fanciulli
Journal:  J Exp Clin Cancer Res       Date:  2017-01-13

Review 5.  mTOR-Dependent Cell Proliferation in the Brain.

Authors:  Larisa Ryskalin; Gloria Lazzeri; Marina Flaibani; Francesca Biagioni; Stefano Gambardella; Alessandro Frati; Francesco Fornai
Journal:  Biomed Res Int       Date:  2017-11-13       Impact factor: 3.411

6.  Promotion Effects of miR-375 on the Osteogenic Differentiation of Human Adipose-Derived Mesenchymal Stem Cells.

Authors:  Si Chen; Yunfei Zheng; Shan Zhang; Lingfei Jia; Yongsheng Zhou
Journal:  Stem Cell Reports       Date:  2017-03-02       Impact factor: 7.765

7.  DEPTOR maintains plasma cell differentiation and favorably affects prognosis in multiple myeloma.

Authors:  Dalia Quwaider; Luis A Corchete; Irena Misiewicz-Krzeminska; María E Sarasquete; José J Pérez; Patryk Krzeminski; Noemí Puig; María Victoria Mateos; Ramón García-Sanz; Ana B Herrero; Norma C Gutiérrez
Journal:  J Hematol Oncol       Date:  2017-04-18       Impact factor: 17.388

Review 8.  Roles of mTOR Signaling in Brain Development.

Authors:  Da Yong Lee
Journal:  Exp Neurobiol       Date:  2015-09-17       Impact factor: 3.261

9.  Leukemia inhibitory factor (LIF) withdrawal activates mTOR signaling pathway in mouse embryonic stem cells through the MEK/ERK/TSC2 pathway.

Authors:  M Y Cherepkova; G S Sineva; V A Pospelov
Journal:  Cell Death Dis       Date:  2016-01-14       Impact factor: 8.469

10.  Functional Genomics Identifies Tis21-Dependent Mechanisms and Putative Cancer Drug Targets Underlying Medulloblastoma Shh-Type Development.

Authors:  Giulia Gentile; Manuela Ceccarelli; Laura Micheli; Felice Tirone; Sebastiano Cavallaro
Journal:  Front Pharmacol       Date:  2016-11-30       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.